Source: BioSpace

Delix received $825K in Grant Funding

Followers on Owler

Est. Annual Revenue

$5.0-25M

Est. Employees

25-100

CEO

Mark Rus

CEO Approval Rating

90/100

Delix is a Massachusetts-based biotechnology company that researches and develops neuroplasticity-promoting therapeutics to treat brain diseases.